Natarajan Sethuraman Entrada Therapeutics, Inc. (TRDA) insider trading activity
Natarajan Sethuraman is President, Research & Develop. of Entrada Therapeutics, Inc.. Currently has a direct ownership of 197,899 shares of TRDA, which is worth approximately $1.22 Million. The most recent transaction as insider was on Sep 05, 2023, when has been sold 449 shares (Common Stock) at a price of $14.46 per share, resulting in proceeds of $6,492. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
198K
0.88%
3M change
8.01%
12M change
Total Value Held
$1.22 Million
Natarajan Sethuraman Transaction History
NS
Natarajan Sethuraman
President, Research & Develop.
Boston, MA